MedPath

ational trial on home ultraviolet B (UVB) phototherapy for psoriasis

Completed
Conditions
Psoriasis
Skin and Connective Tissue Diseases
Registration Number
ISRCTN83025173
Lead Sponsor
niversity Medical Centre Utrecht (UMCU) (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
196
Inclusion Criteria

1. Psoriasis patients: plaque or guttata psoriasis
2. Eligible for total-body home UVB phototherapy based on the severity of the psoriatic skin lesions
3. Willing AND capable to participate in both possible treatment arms (treatment at home and in the hospital)
4. Sufficient knowledge of the dutch language
5. Age 18 years or more
6. Does have a telephone

Exclusion Criteria

1. Analphabetism
2. Expected non-compliance
3. History of malignancy of the skin
4. Known UVB allergy
5. Chronic polymorphic light eruption (CPLE)
6. Use of (systemic) medication with known phototoxic or photo-allergic properties
7. Use of the following systemic medication: cyclosporin (neoral), methotrexate, acitretin (neotigason)
8. History of ionising radiation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath